Expression changes of transforming growth factor-beta1 and thrombospondin-1 in cavernous tissues of diabetic rats

Urologia Internationalis

Volumn 84, Issue 2, 2010, Pages 221-225

  Zhang, Xiao Ming ^b   Shi, Pei Hua ^a   Cao, Sai Hong ^a   Yu, He Jun ^a   Azad, Junaid ^b   Ling, Shu Cai ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cavernous tissue; Diabetes; Erectile dysfunction; Thrombospondin 1; Transforming growth factor 1

Indexed keywords

EOSIN; GLUCOSE; HEMATOXYLIN; STREPTOZOCIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS CAVERNOSUM; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STAINING; STREPTOZOCIN DIABETES; TISSUE STRUCTURE; UPREGULATION;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; ERECTILE DYSFUNCTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77949406671     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277602     Document Type: Article

References (23)

1. Hauri D: Erectile dysfunction in the elderly man. Urol Int 2003;70:89-99.
2. Selvin E, Burnett AL, Platz EA: Prevalence and risk factors for erectile dysfunction in the US. Am J Med 2007;120:151-157.
3. Parazzini F, Menchini Fabris F, Bortolotti A, Calabro A, Chatenoud L, Colli E, Landoni M, Lavezzari M, Turchi P, Sessa A, Mirone V: Frequency and determinants of erectile dysfunction in Italy. Eur Urol 2000;37:43-49.
4. Huang X, Li S, Hu L: Growth hormone deficiency and age-related erectile dysfunction (in Chinese). Zhonghua Nan Ke Xue 2004;10:867-869.
5. Saenz de Tejada I, Angulo J, Cellek S, Gonzalez-Cadavid N, Heaton J, Pickard R, Simonsen U: Pathophysiology of erectile dysfunction. J Sex Med 2005;2:26-39.
6. Moore CR, Wang R: Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl 2006;8:675-684.
7. Zhang XM, Shen F, Xv ZY, Yan ZY, Han S: Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int J Cardiol 2005;105:192-197.
8. Hu WL, Hu LQ, Song J, Li SW, Zheng XM, Cheng B, Tian BC: Fibrosis of corpus cavernosum in animals following cavernous nerve ablation. Asian J Androl 2004;6:111-116.
9. Ryu JK, Song SU, Han JY, Chu YC, Lee M, Kim JS, Kim SJ, Suh JK: Establishment of penile fibrosis model in a rat using mouse NIH 3T3 fibroblasts expressing transforming growth factor beta1. Biol Reprod 2005;72:916-921.
10. Ryu JK, Song SU, Choi HK, Seong DH, Yoon SM, Kim SJ, Suh JK: Plasma transforming growth factor-beta1 levels in patients with erectile dysfunction. Asian J Androl 2004;6:349-353.
11. Hosomi N, Noma T, Ohyama H, Takahashi T, Kohno M: Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Atherosclerosis 2002;162:69-76.
12. McGowan TA, Dunn SR, Falkner B, Sharma K: Stimulation of urinary TGF-beta and isoprostanes in response to hyperglycemia in humans. Clin J Am Soc Nephrol 2006;1:263-268.
13. McGillicuddy FC, O'Toole D, Hickey JA, Gallagher WM, Dawson KA, Keenan AK: TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol 2006;44:469-475.
14. Hugo C: The thrombospondin 1-TGF-beta axis in fibrotic renal disease. Nephrol Dial Transplant 2003;18:1241-1245.
15. Budhani F, Leonard KA, Bergdahl A, Gao J, Lawler J, Davis EC: Vascular response to intra-arterial injury in the thrombospondin-1 null mouse. J Mol Cell Cardiol 2007;43:210-214.
16. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML: Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005;111:2935-2942.
17. Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE: Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophysic Res Commun 2006;339:633-641.
18. Daniel C, Schaub K, Amann K, Lawler J, Hugo C: Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Diabetes 2007;56:2982-2989.
19. Zhou J, Wang L, Ling S, Zhang X: Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-induced diabetic cognitive impairment rats. Exp Neurol 2007;206:201-208.
20. Weng Y, Shen F, Li J, Shen Y, Zhang X: Expression changes of mitogen-activated protein kinase phosphatase-1 (MKP-1) in myocardium of streptozotocin-induced diabetic rats. Exp Clin Endocrinol Diabetes 2007;115:455-460.
21. Bhasin S, Enzlin P, Coviello A, Basson R: Sexual dysfunction in men and women with endocrine disorders. Lancet 2007;369:597-611.
22. Haag SM, Hauck EW, Szardening-Kirchner C, Diemer T, Cha ES, Weidner W, Eickelberg O: Alterations in the transforming growth factor (TGF)-beta pathway as a potential factor in the pathogenesis of Peyronie's disease. Eur Urol 2007;51:255-261.
23. Murphy-Ullrich JE, Poczatek M: Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 2000;11:59-69.